These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 9636582

  • 1. Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy.
    Mies S, Massarollo PC, Figueira ER, Leitão RM, Raia S.
    Transplant Proc; 1998 Jun; 30(4):1437-8. PubMed ID: 9636582
    [No Abstract] [Full Text] [Related]

  • 2. Early cyclosporine blood levels impact the incidence of acute rejection and overall mortality in the first year after heart transplantation.
    Gómez-Sánchez MA, Delgado JF, Escribano P, Santos M, Sotelo T, Gil R, Hernández-Afonso J, Ortuño B, Romero F, Sáenz de la Calzada C, Rodriguez JE, Rufilanchas JJ.
    Transplant Proc; 1998 Aug; 30(5):1671-2. PubMed ID: 9723237
    [No Abstract] [Full Text] [Related]

  • 3. FK506 for primary and rescue therapy following liver transplantation.
    Platz KP, Mueller AR, Zytowski M, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
    [No Abstract] [Full Text] [Related]

  • 4. Reduction of early rejection in adult liver transplantation with ATG induction therapy.
    Schulak J, May E, Post A, Fasola C, Mulligan D, Sterling R.
    Transplant Proc; 1997 Jun; 29(1-2):555-6. PubMed ID: 9123126
    [No Abstract] [Full Text] [Related]

  • 5. Does initial graft function influence the outcome after liver transplantation?
    Mueller AR, Platz KP, Krause P, Neuhaus R, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1464-5. PubMed ID: 9636594
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of calcium channel blockers in renal allograft patients receiving cyclosporine.
    Suh BY, Kwun OS, Kwun KB.
    Transplant Proc; 1998 Nov; 30(7):3558-60. PubMed ID: 9838558
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.
    Maggi U, Rossi G, Vannelli A, Caccamo L, Gatti S, Paone G, Reggiani P, Melada E, Latham L, Andreani P, Fassati LR.
    Transplant Proc; 1998 Dec; 30(8):3946-7. PubMed ID: 9865255
    [No Abstract] [Full Text] [Related]

  • 10. Impact of immunosuppression in liver transplantation across a positive crossmatch.
    Lang M, Neumann U, Knoop M, Bechstein WO, Neuhaus P.
    Transplant Proc; 1998 Jun; 30(4):1466-7. PubMed ID: 9636595
    [No Abstract] [Full Text] [Related]

  • 11. Increased dosage requirement and rejection after Neoral conversion in pediatric liver transplant patients.
    Cao S, Cox KL, Berquist W, So S, Concepcion W, Monge H, Esquivel CO.
    Transplant Proc; 1998 Dec; 30(8):4322-4. PubMed ID: 9865373
    [No Abstract] [Full Text] [Related]

  • 12. Reduced acute rejection after liver transplantation with Neoral-based double immunosuppression.
    Reggiani P, Rossi G, Latham L, Caccamo L, Gatti S, Maggi U, Melada E, Paone G, Doglia M, Vannelli A, Fassati LR.
    Transplant Proc; 1998 Aug; 30(5):1855-6. PubMed ID: 9723308
    [No Abstract] [Full Text] [Related]

  • 13. A randomized trial comparing cyclosporine induction with sequential therapy in renal transplant recipients.
    Kasiske BL, Johnson HJ, Goerdt PJ, Heim-Duthoy KL, Rao VK, Dahl DC, Ney AL, Andersen RC, Jacobs DM, Odland MD.
    Am J Kidney Dis; 1997 Nov; 30(5):639-45. PubMed ID: 9370178
    [Abstract] [Full Text] [Related]

  • 14. Safety, tolerability, and pharmacokinetic actions of diltiazem in pediatric liver transplant recipients on cyclosporine.
    al Edreesi M, Caillé G, Dupuis C, Théoret Y, Paradis K.
    Liver Transpl Surg; 1995 Nov; 1(6):383-8. PubMed ID: 9346617
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Incidence and outcome of OKT3 treatment for early steroid-resistant rejection following hepatic transplantation.
    Lange D, Bechstein WO, Blumhardt G, Lemmens P, Schattenfroh N, Neuhaus P.
    Transplant Proc; 1993 Apr; 25(2):1870-1. PubMed ID: 8470207
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO, Wheatley T, Feehally J, Nicholson ML, Veitch PS, Bell PR.
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.